TreeWAS – Variant ID: rs28732236

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
J33 Nasal polyp	0.000	0.000	1.000
L40 Psoriasis	1.000	0.000	0.000
J40-J47 Chronic lower respiratory diseases	0.000	0.000	1.000
# Top node	1.000	0.000	0.000
J30-J39 Other diseases of upper respiratory tract	0.000	0.000	1.000
Chapter X Diseases of the respiratory system	0.000	0.000	1.000
Chapter V Mental and behavioural disorders	1.000	0.000	0.000
J47 Bronchiectasis	0.000	0.000	1.000
Chapter II Neoplasms	1.000	0.000	0.000
J45 Asthma	0.000	0.000	1.000
J45.9 Asthma, unspecified	0.000	0.000	1.000
T36-T50 Poisoning by drugs, medicaments and biological substances	1.000	0.000	0.000
E03.9 Hypothyroidism, unspecified	0.000	0.000	1.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	1.000	0.000	0.000
J33.9 Nasal polyp, unspecified	0.000	0.000	1.000
E03 Other hypothyroidism	0.000	0.001	0.999
E00-E07 Disorders of thyroid gland	0.000	0.001	0.999
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.003	0.997
J33.0 Polyp of nasal cavity	0.000	0.004	0.996
F30-F39 Mood [affective] disorders	0.996	0.004	0.000
L40-L45 Papulosquamous disorders	0.995	0.005	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.995	0.005	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.993	0.007	0.000
C15-C26 Malignant neoplasms of digestive organs	0.993	0.007	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.992	0.008	0.000
Chapter VI Diseases of the nervous system	0.992	0.008	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.012	0.988
J44 Other chronic obstructive pulmonary disease	0.000	0.014	0.986
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.985	0.015	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.984	0.016	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.977	0.023	0.000
F41 Other anxiety disorders	0.976	0.024	0.000
F31 Bipolar affective disorder	0.968	0.032	0.000
T39.1 4-Aminophenol derivatives	0.967	0.033	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.014	0.034	0.952
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.965	0.035	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.036	0.964
E10-E14 Diabetes mellitus	0.011	0.038	0.952
E10 Insulin-dependent diabetes mellitus	0.001	0.038	0.961
E10.9 Without complications	0.000	0.041	0.959
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.041	0.959
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.952	0.048	0.000
C18 Malignant neoplasm of colon	0.944	0.056	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.938	0.062	0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.938	0.062	0.000
T43.2 Other and unspecified antidepressants	0.937	0.063	0.000
C18.7 Sigmoid colon	0.937	0.063	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.068	0.932
L40.0 Psoriasis vulgaris	0.927	0.073	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.926	0.074	0.000
F60-F69 Disorders of adult personality and behaviour	0.926	0.074	0.000
M07.3 Other psoriatic arthropathies	0.924	0.075	0.000
G20-G26 Extrapyramidal and movement disorders	0.924	0.076	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.923	0.077	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.920	0.080	0.000
M07 Psoriatic and enteropathic arthropathies	0.911	0.085	0.004
E10.3 With ophthalmic complications	0.000	0.086	0.914
F31.9 Bipolar affective disorder, unspecified	0.914	0.086	0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.912	0.088	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.000	0.089	0.911
M05-M14 Inflammatory polyarthropathies	0.902	0.090	0.009
M07.30 Other psoriatic arthropathies (Multiple sites)	0.907	0.093	0.000
F33 Recurrent depressive disorder	0.904	0.096	0.000
J33.8 Other polyp of sinus	0.000	0.098	0.902
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.900	0.099	0.001
E07 Other disorders of thyroid	0.000	0.103	0.897
G50-G59 Nerve, nerve root and plexus disorders	0.896	0.104	0.000
F45 Somatoform disorders	0.895	0.105	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.895	0.105	0.000
Q21 Congenital malformations of cardiac septa	0.892	0.108	0.000
C21 Malignant neoplasm of anus and anal canal	0.888	0.112	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.887	0.113	0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.114	0.886
T51 Toxic effect of alcohol	0.881	0.119	0.000
C64-C68 Malignant neoplasms of urinary tract	0.877	0.123	0.000
D00-D09 In situ neoplasms	0.877	0.123	0.000
G70-G73 Diseases of myoneural junction and muscle	0.876	0.124	0.000
F60 Specific personality disorders	0.873	0.127	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.871	0.129	0.000
C20 Malignant neoplasm of rectum	0.870	0.130	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.867	0.133	0.000
G56 Mononeuropathies of upper limb	0.866	0.134	0.000
G20 Parkinson's disease	0.863	0.137	0.000
F41.1 Generalised anxiety disorder	0.861	0.139	0.000
G90-G99 Other disorders of the nervous system	0.860	0.140	0.000
G40-G47 Episodic and paroxysmal disorders	0.859	0.141	0.000
Q80-Q89 Other congenital malformations	0.853	0.147	0.000
Q21.1 Atrial septal defect	0.853	0.147	0.000
F30 Manic episode	0.852	0.148	0.000
C51-C58 Malignant neoplasms of female genital organs	0.851	0.149	0.000
J42 Unspecified chronic bronchitis	0.000	0.151	0.849
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.848	0.152	0.000
G56.0 Carpal tunnel syndrome	0.847	0.153	0.000
J60-J70 Lung diseases due to external agents	0.000	0.159	0.841
J45.0 Predominantly allergic asthma	0.000	0.159	0.841
E10.1 With ketoacidosis	0.000	0.162	0.837
F41.2 Mixed anxiety and depressive disorder	0.837	0.163	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.837	0.163	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.835	0.165	0.000
T51.0 Ethanol	0.833	0.167	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.830	0.170	0.000
S32 Fracture of lumbar spine and pelvis	0.827	0.173	0.000
J34 Other disorders of nose and nasal sinuses	0.000	0.174	0.826
T20-T25 Burns and corrosions of external body surface, specified by site	0.825	0.175	0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.000	0.175	0.825
E07.9 Disorder of thyroid, unspecified	0.000	0.176	0.824
C18.9 Colon, unspecified	0.824	0.176	0.000
F45.8 Other somatoform disorders	0.823	0.177	0.000
F32 Depressive episode	0.823	0.177	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.819	0.180	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.819	0.181	0.000
J36 Peritonsillar abscess	0.000	0.189	0.811
F31.8 Other bipolar affective disorders	0.810	0.190	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.810	0.190	0.000
T42.4 Benzodiazepines	0.810	0.190	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.807	0.193	0.000
C82.0 Small cleaved cell, follicular	0.807	0.193	0.000
J81 Pulmonary oedema	0.000	0.194	0.806
C64 Malignant neoplasm of kidney, except renal pelvis	0.805	0.195	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.805	0.195	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.805	0.195	0.000
F42 Obsessive-compulsive disorder	0.805	0.195	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.805	0.195	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.804	0.196	0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.803	0.197	0.000
J32 Chronic sinusitis	0.000	0.198	0.802
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.800	0.200	0.000
C21.1 Anal canal	0.800	0.200	0.000
C91 Lymphoid leukaemia	0.796	0.204	0.000
F40 Phobic anxiety disorders	0.796	0.204	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.794	0.206	0.000
F44 Dissociative [conversion] disorders	0.794	0.206	0.000
Q50-Q56 Congenital malformations of genital organs	0.794	0.206	0.000
C17 Malignant neoplasm of small intestine	0.793	0.207	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.792	0.208	0.000
S10-S19 Injuries to the neck	0.791	0.209	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.790	0.210	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.789	0.211	0.000
G70 Myasthenia gravis and other myoneural disorders	0.788	0.212	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.787	0.213	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.787	0.213	0.000
J46 Status asthmaticus	0.000	0.216	0.784
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.782	0.217	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.782	0.218	0.000
S20-S29 Injuries to the thorax	0.781	0.219	0.000
E06 Thyroiditis	0.000	0.219	0.781
J30 Vasomotor and allergic rhinitis	0.000	0.220	0.780
L50-L54 Urticaria and erythema	0.779	0.221	0.000
F60.9 Personality disorder, unspecified	0.779	0.221	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.222	0.778
G51 Facial nerve disorders	0.777	0.223	0.000
G40 Epilepsy	0.774	0.226	0.000
J34.2 Deviated nasal septum	0.000	0.226	0.774
F60.3 Emotionally unstable personality disorder	0.772	0.228	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.771	0.229	0.000
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.769	0.231	0.000
C25 Malignant neoplasm of pancreas	0.769	0.231	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.768	0.232	0.000
M06.9 Rheumatoid arthritis, unspecified	0.005	0.232	0.763
Chapter XXII Codes for special purposes	0.767	0.233	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.765	0.234	0.000
C56 Malignant neoplasm of ovary	0.764	0.236	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.763	0.237	0.000
M60-M63 Disorders of muscles	0.760	0.239	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.757	0.243	0.000
G96 Other disorders of central nervous system	0.755	0.245	0.000
Q21.0 Ventricular septal defect	0.754	0.246	0.000
T39.0 Salicylates	0.753	0.247	0.000
J84 Other interstitial pulmonary diseases	0.000	0.250	0.750
J95-J99 Other diseases of the respiratory system	0.000	0.254	0.746
G24 Dystonia	0.743	0.257	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.741	0.258	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.740	0.260	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.738	0.261	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.738	0.261	0.000
F99-F99 Unspecified mental disorder	0.738	0.262	0.000
C34 Malignant neoplasm of bronchus and lung	0.735	0.265	0.000
J00-J06 Acute upper respiratory infections	0.000	0.266	0.734
T15-T19 Effects of foreign body entering through natural orifice	0.728	0.272	0.000
G70.0 Myasthenia gravis	0.726	0.274	0.000
D05 Carcinoma in situ of breast	0.726	0.274	0.000
G45.9 Transient cerebral ischaemic attack, unspecified	0.723	0.277	0.000
Q00-Q07 Congenital malformations of the nervous system	0.721	0.279	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.001	0.280	0.720
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.009	0.282	0.709
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.718	0.282	0.000
S40-S49 Injuries to the shoulder and upper arm	0.718	0.282	0.000
J33.1 Polypoid sinus degeneration	0.000	0.283	0.717
L40.8 Other psoriasis	0.717	0.283	0.000
L40.4 Guttate psoriasis	0.717	0.283	0.000
L40.3 Pustulosis palmaris et plantaris	0.717	0.283	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
L40.1 Generalised pustular psoriasis	0.717	0.283	0.000
J41 Simple and mucopurulent chronic bronchitis	0.000	0.283	0.717
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283	0.000
J37 Chronic laryngitis and laryngotracheitis	0.000	0.283	0.717
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.717	0.283	0.000
F70-F79 Mental retardation	0.717	0.283	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.717	0.283	0.000
J45.8 Mixed asthma	0.000	0.283	0.717
J45.1 Nonallergic asthma	0.000	0.283	0.717
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.717	0.283	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.717	0.283	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.717	0.283	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.717	0.283	0.000
T36 Poisoning by systemic antibiotics	0.717	0.283	0.000
T33-T35 Frostbite	0.717	0.283	0.000
T26-T28 Burns and corrosions confined to eye and internal organs	0.717	0.283	0.000
T00-T07 Injuries involving multiple body regions	0.717	0.283	0.000
E03.8 Other specified hypothyroidism	0.000	0.283	0.716
E03.5 Myxoedema coma	0.000	0.283	0.716
E03.4 Atrophy of thyroid (acquired)	0.000	0.283	0.716
E03.3 Postinfectious hypothyroidism	0.000	0.283	0.716
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.283	0.716
E03.1 Congenital hypothyroidism without goitre	0.000	0.283	0.716
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.283	0.716
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.283	0.716
E00 Congenital iodine-deficiency syndrome	0.000	0.283	0.716
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.283	0.716
S90-S99 Injuries to the ankle and foot	0.716	0.284	0.000
T51.9 Alcohol, unspecified	0.716	0.284	0.000
J38.7 Other diseases of larynx	0.000	0.284	0.716
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.285	0.715
E05.8 Other thyrotoxicosis	0.000	0.285	0.714
E05.5 Thyroid crisis or storm	0.000	0.285	0.714
E05.4 Thyrotoxicosis factitia	0.000	0.285	0.714
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.285	0.714
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.285	0.714
F38 Other mood [affective] disorders	0.714	0.286	0.000
F34 Persistent mood [affective] disorders	0.714	0.286	0.000
F39 Unspecified mood [affective] disorder	0.714	0.286	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.714	0.286	0.000
D07.1 Vulva	0.714	0.286	0.000
L44 Other papulosquamous disorders	0.714	0.286	0.000
L41 Parapsoriasis	0.714	0.286	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.714	0.286	0.000
L42 Pityriasis rosea	0.714	0.286	0.000
F48 Other neurotic disorders	0.713	0.287	0.000
L10-L14 Bullous disorders	0.712	0.288	0.000
C23 Malignant neoplasm of gallbladder	0.712	0.288	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.711	0.289	0.000
C95 Leukaemia of unspecified cell type	0.711	0.289	0.000
C94 Other leukaemias of specified cell type	0.711	0.289	0.000
C93 Monocytic leukaemia	0.711	0.289	0.000
C88 Malignant immunoproliferative diseases	0.711	0.289	0.000
C86 Other specified types of T/NK-cell lymphoma	0.711	0.289	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.711	0.289	0.000
C81 Hodgkin's disease	0.711	0.289	0.000
F32.1 Moderate depressive episode	0.711	0.289	0.000
E14 Unspecified diabetes mellitus	0.004	0.292	0.704
T47.1 Other antacids and anti-gastric-secretion drugs	0.708	0.292	0.000
G45.3 Amaurosis fugax	0.707	0.293	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.706	0.294	0.000
Q35-Q37 Cleft lip and cleft palate	0.706	0.294	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.706	0.294	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.706	0.294	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.706	0.294	0.000
T39.4 Antirheumatics, not elsewhere classified	0.706	0.294	0.000
T39.2 Pyrazolone derivatives	0.706	0.294	0.000
F30.0 Hypomania	0.706	0.294	0.000
S32.0 Fracture of lumbar vertebra	0.705	0.295	0.000
C32 Malignant neoplasm of larynx	0.704	0.296	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.702	0.297	0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.000	0.298	0.702
J38.0 Paralysis of vocal cords and larynx	0.000	0.299	0.701
Q60-Q64 Congenital malformations of the urinary system	0.701	0.299	0.000
C82.6 Cutaneous follicle centre lymphoma	0.700	0.300	0.000
C82.5 Diffuse follicle centre lymphoma	0.700	0.300	0.000
C82.4 Follicular lymphoma grade IIIb	0.700	0.300	0.000
C82.3 Follicular lymphoma grade IIIa	0.700	0.300	0.000
C82.2 Large cell, follicular	0.700	0.300	0.000
M11 Other crystal arthropathies	0.694	0.300	0.006
F41.8 Other specified anxiety disorders	0.700	0.300	0.000
F41.3 Other mixed anxiety disorders	0.700	0.300	0.000
M13 Other arthritis	0.696	0.300	0.004
G56.1 Other lesions of median nerve	0.700	0.300	0.000
J31.0 Chronic rhinitis	0.000	0.301	0.699
M06 Other rheumatoid arthritis	0.357	0.301	0.343
C83 Diffuse non-Hodgkin's lymphoma	0.699	0.301	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.699	0.301	0.000
J38.3 Other diseases of vocal cords	0.000	0.302	0.698
G00-G09 Inflammatory diseases of the central nervous system	0.698	0.302	0.000
J32.0 Chronic maxillary sinusitis	0.000	0.303	0.697
T79-T79 Certain early complications of trauma	0.697	0.303	0.000
Q83 Congenital malformations of breast	0.696	0.304	0.000
F31.7 Bipolar affective disorder, currently in remission	0.694	0.306	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.694	0.306	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.694	0.306	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.694	0.306	0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.694	0.306	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.692	0.308	0.000
T43.9 Psychotropic drug, unspecified	0.692	0.308	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.692	0.308	0.000
T43.6 Psychostimulants with abuse potential	0.692	0.308	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.692	0.308	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.692	0.308	0.000
G93 Other disorders of brain	0.691	0.309	0.000
E12 Malnutrition-related diabetes mellitus	0.008	0.310	0.682
S70-S79 Injuries to the hip and thigh	0.689	0.310	0.000
E10.8 With unspecified complications	0.001	0.310	0.689
E10.7 With multiple complications	0.001	0.310	0.689
E10.6 With other specified complications	0.001	0.310	0.689
E10.5 With peripheral circulatory complications	0.001	0.310	0.689
E10.4 With neurological complications	0.001	0.310	0.689
E10.2 With renal complications	0.001	0.310	0.689
E10.0 With coma	0.001	0.310	0.689
J38.2 Nodules of vocal cords	0.000	0.311	0.689
T91 Sequelae of injuries of neck and trunk	0.688	0.312	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.688	0.312	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.687	0.313	0.000
C22.9 Liver, unspecified	0.687	0.313	0.000
D07.5 Prostate	0.687	0.313	0.000
S32.1 Fracture of sacrum	0.684	0.316	0.000
F33.9 Recurrent depressive disorder, unspecified	0.684	0.316	0.000
F30.9 Manic episode, unspecified	0.683	0.317	0.000
G90 Disorders of autonomic nervous system	0.683	0.317	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.682	0.317	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.682	0.317	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.682	0.317	0.000
T42.3 Barbiturates	0.682	0.317	0.000
T42.2 Succinimides and oxazolidinediones	0.682	0.317	0.000
T42.1 Iminostilbenes	0.682	0.317	0.000
T42.0 Hydantoin derivatives	0.682	0.317	0.000
C79 Secondary malignant neoplasm of other sites	0.682	0.318	0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.000	0.318	0.682
C26 Malignant neoplasm of other and ill-defined digestive organs	0.681	0.319	0.000
F80-F89 Disorders of psychological development	0.679	0.321	0.000
M91-M94 Chondropathies	0.677	0.322	0.001
J03 Acute tonsillitis	0.000	0.322	0.678
C18.8 Overlapping lesion of colon	0.677	0.323	0.000
C18.1 Appendix	0.677	0.323	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.677	0.323	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.675	0.325	0.000
C21.0 Anus, unspecified	0.675	0.325	0.000
M14 Arthropathies in other diseases classified elsewhere	0.669	0.325	0.006
E40-E46 Malnutrition	0.010	0.326	0.664
C73 Malignant neoplasm of thyroid gland	0.674	0.326	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.674	0.326	0.000
S32.4 Fracture of acetabulum	0.672	0.327	0.000
J69 Pneumonitis due to solids and liquids	0.000	0.329	0.671
Q76 Congenital malformations of spine and bony thorax	0.670	0.330	0.000
T92 Sequelae of injuries of upper limb	0.669	0.331	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.669	0.331	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.669	0.331	0.000
F42.9 Obsessive-compulsive disorder, unspecified	0.668	0.331	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.668	0.331	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.668	0.332	0.000
Q82 Other congenital malformations of skin	0.667	0.333	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.002	0.333	0.664
C51 Malignant neoplasm of vulva	0.666	0.334	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.665	0.335	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.664	0.335	0.000
T65 Toxic effect of other and unspecified substances	0.664	0.336	0.000
T62 Toxic effect of other noxious substances eaten as food	0.664	0.336	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.664	0.336	0.000
T60 Toxic effect of pesticides	0.664	0.336	0.000
T59 Toxic effect of other gases, fumes and vapours	0.664	0.336	0.000
T57 Toxic effect of other inorganic substances	0.664	0.336	0.000
T56 Toxic effect of metals	0.664	0.336	0.000
T54 Toxic effect of corrosive substances	0.664	0.336	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.664	0.336	0.000
T52 Toxic effect of organic solvents	0.664	0.336	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.664	0.336	0.000
T58 Toxic effect of carbon monoxide	0.664	0.336	0.000
T55 Toxic effect of soaps and detergents	0.664	0.336	0.000
C22.1 Intrahepatic bile duct carcinoma	0.664	0.336	0.000
F68 Other disorders of adult personality and behaviour	0.664	0.336	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.664	0.336	0.000
F65 Disorders of sexual preference	0.664	0.336	0.000
F64 Gender identity disorders	0.664	0.336	0.000
F63 Habit and impulse disorders	0.664	0.336	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.664	0.336	0.000
F69 Unspecified disorder of adult personality and behaviour	0.664	0.336	0.000
F61 Mixed and other personality disorders	0.664	0.336	0.000
J80 Adult respiratory distress syndrome	0.000	0.337	0.663
C18.4 Transverse colon	0.663	0.337	0.000
M07.38 Other psoriatic arthropathies (Other)	0.663	0.337	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.663	0.337	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.663	0.337	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.663	0.337	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.663	0.337	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.663	0.337	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.663	0.337	0.000
J38.1 Polyp of vocal cord and larynx	0.000	0.337	0.663
G23 Other degenerative diseases of basal ganglia	0.662	0.338	0.000
G21 Secondary Parkinsonism	0.662	0.338	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.662	0.338	0.000
G22 Parkinsonism in diseases classified elsewhere	0.662	0.338	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.662	0.338	0.000
Q28 Other congenital malformations of circulatory system	0.661	0.338	0.000
Q27 Other congenital malformations of peripheral vascular system	0.661	0.338	0.000
Q26 Congenital malformations of great veins	0.661	0.338	0.000
Q25 Congenital malformations of great arteries	0.661	0.338	0.000
Q24 Other congenital malformations of heart	0.661	0.338	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.661	0.338	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.661	0.338	0.000
M62 Other disorders of muscle	0.660	0.339	0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.660	0.340	0.000
M40-M43 Deforming dorsopathies	0.659	0.341	0.000
E50-E64 Other nutritional deficiencies	0.008	0.341	0.651
T23 Burn and corrosion of wrist and hand	0.657	0.343	0.000
G50 Disorders of trigeminal nerve	0.656	0.343	0.000
M07.6 Other enteropathic arthropathies	0.653	0.344	0.003
M07.5 Arthropathy in ulcerative colitis	0.653	0.344	0.003
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.653	0.344	0.003
M07.2 Psoriatic spondylitis	0.653	0.344	0.003
M07.1 Arthritis mutilans	0.653	0.344	0.003
M07.0 Distal interphalangeal psoriatic arthropathy	0.653	0.344	0.003
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.654	0.346	0.000
S37 Injury of urinary and pelvic organs	0.654	0.346	0.000
S36 Injury of intra-abdominal organs	0.654	0.346	0.000
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.654	0.346	0.000
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.654	0.346	0.000
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.654	0.346	0.000
S31 Open wound of abdomen, lower back and pelvis	0.654	0.346	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.346	0.654
J82 Pulmonary eosinophilia, not elsewhere classified	0.000	0.347	0.653
Q51 Congenital malformations of uterus and cervix	0.653	0.347	0.000
M12 Other specific arthropathies	0.646	0.347	0.006
M09 Juvenile arthritis in diseases classified elsewhere	0.646	0.347	0.006
M08 Juvenile arthritis	0.646	0.347	0.006
E13 Other specified diabetes mellitus	0.008	0.347	0.645
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.652	0.348	0.000
C66 Malignant neoplasm of ureter	0.650	0.349	0.000
F44.5 Dissociative convulsions	0.649	0.350	0.000
F33.8 Other recurrent depressive disorders	0.648	0.352	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.648	0.352	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.648	0.352	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.648	0.352	0.000
F32.9 Depressive episode, unspecified	0.648	0.352	0.000
T90 Sequelae of injuries of head	0.647	0.353	0.000
G61 Inflammatory polyneuropathy	0.647	0.353	0.000
M00-M03 Infectious arthropathies	0.646	0.354	0.001
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.646	0.354	0.000
G91 Hydrocephalus	0.646	0.354	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.645	0.355	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.645	0.355	0.000
C12 Malignant neoplasm of pyriform sinus	0.645	0.355	0.000
C91.1 Chronic lymphocytic leukaemia	0.644	0.356	0.000
C25.0 Head of pancreas	0.643	0.356	0.000
E07.8 Other specified disorders of thyroid	0.000	0.357	0.643
E07.1 Dyshormogenetic goitre	0.000	0.357	0.643
E07.0 Hypersecretion of calcitonin	0.000	0.357	0.643
L52 Erythema nodosum	0.643	0.357	0.000
G54 Nerve root and plexus disorders	0.642	0.358	0.000
G53 Cranial nerve disorders in diseases classified elsewhere	0.642	0.358	0.000
G52 Disorders of other cranial nerves	0.642	0.358	0.000
F45.9 Somatoform disorder, unspecified	0.642	0.358	0.000
F45.4 Persistent somatoform pain disorder	0.642	0.358	0.000
F45.3 Somatoform autonomic dysfunction	0.642	0.358	0.000
F45.2 Hypochondriacal disorder	0.642	0.358	0.000
F45.1 Undifferentiated somatoform disorder	0.642	0.358	0.000
F45.0 Somatisation disorder	0.642	0.358	0.000
T38.9 Other and unspecified hormone antagonists	0.641	0.358	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.641	0.358	0.000
T38.7 Androgens and anabolic congeners	0.641	0.358	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.641	0.358	0.000
T38.5 Other oestrogens and progestogens	0.641	0.358	0.000
T38.4 Oral contraceptives	0.641	0.358	0.000
T38.2 Antithyroid drugs	0.641	0.358	0.000
T38.1 Thyroid hormones and substitutes	0.641	0.358	0.000
T38.0 Glucocorticoids and synthetic analogues	0.641	0.358	0.000
G71 Primary disorders of muscles	0.641	0.358	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.640	0.360	0.000
Q21.9 Congenital malformation of cardiac septum, unspecified	0.640	0.360	0.000
Q21.8 Other congenital malformations of cardiac septa	0.640	0.360	0.000
Q21.4 Aortopulmonary septal defect	0.640	0.360	0.000
Q21.3 Tetralogy of Fallot	0.640	0.360	0.000
Q21.2 Atrioventricular septal defect	0.640	0.360	0.000
G30-G32 Other degenerative diseases of the nervous system	0.639	0.360	0.000
C53 Malignant neoplasm of cervix uteri	0.639	0.361	0.000
K90 Intestinal malabsorption	0.000	0.362	0.638
J03.9 Acute tonsillitis, unspecified	0.000	0.363	0.637
C21.8 Overlapping lesion of rectum, anus and anal canal	0.637	0.363	0.000
C21.2 Cloacogenic zone	0.637	0.363	0.000
C09 Malignant neoplasm of tonsil	0.637	0.363	0.000
G96.0 Cerebrospinal fluid leak	0.636	0.364	0.000
J38.6 Stenosis of larynx	0.000	0.364	0.635
C90.0 Multiple myeloma	0.635	0.365	0.000
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified	0.635	0.365	0.000
D46 Myelodysplastic syndromes	0.635	0.365	0.000
S19 Other and unspecified injuries of neck	0.633	0.366	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.633	0.367	0.000
T51.8 Other alcohols	0.632	0.368	0.000
T51.3 Fusel oil	0.632	0.368	0.000
T51.2 2-Propanol	0.632	0.368	0.000
T51.1 Methanol	0.632	0.368	0.000
C18.3 Hepatic flexure	0.630	0.370	0.000
G60 Hereditary and idiopathic neuropathy	0.629	0.371	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.629	0.371	0.000
C65 Malignant neoplasm of renal pelvis	0.629	0.371	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.628	0.371	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.628	0.371	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.628	0.371	0.000
S22 Fracture of rib(s), sternum and thoracic spine	0.629	0.371	0.000
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.628	0.372	0.000
G51.9 Disorder of facial nerve, unspecified	0.627	0.373	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations